Radiopharm Theranostics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	58	34	12	24	26	-
Market Cap Growth	57.96%	192.24%	-50.78%	-10.18%	-	-
Enterprise Value	32	9	10	8	4	-
Last Close Price	4.99	4.64	-	-	-	-
PS Ratio	5.56	4.16	8.93	5.74	-	-
PB Ratio	1.74	1.21	0.64	0.78	0.61	-
P/TBV Ratio	12.99	-	-	-	5.56	-
EV/Sales Ratio	3.08	1.15	8.02	2.04	-	-
Debt / Equity Ratio	-	-	-	-	-	-0.47
Net Debt / Equity Ratio	-0.69	-0.68	-0.68	-0.26	-0.43	-0.26
Net Debt / EBITDA Ratio	0.87	0.90	0.58	0.46	1.59	-
Net Debt / FCF Ratio	0.93	0.80	0.81	0.50	2.72	-0.40
Asset Turnover	0.17	0.16	0.03	0.08	-	-
Quick Ratio	3.00	2.65	1.11	1.22	3.43	0.21
Current Ratio	3.01	2.67	1.30	1.23	3.46	0.21
Return on Equity (ROE)	-92.10%	-109.20%	-131.49%	-63.78%	-96.82%	-
Return on Assets (ROA)	-28.75%	-27.70%	-30.04%	-22.57%	-29.86%	-
Return on Capital Employed (ROCE)	-55.70%	-49.10%	-64.90%	-46.30%	-26.40%	932.90%
Earnings Yield	-53.50%	-73.69%	-274.09%	-97.15%	-79.40%	-
FCF Yield	-45.46%	-70.43%	-131.34%	-65.25%	-25.86%	-
Buyback Yield / Dilution	-114.63%	-438.49%	-26.36%	-68.74%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q